CooperCompanies Announces Release Date for First Quarter 2026
Rhea-AI Summary
CooperCompanies (Nasdaq: COO) will report first quarter 2026 financial results on Thursday, March 5, 2026 at 4:15 PM ET. A conference call will follow at 5:00 PM ET with dial-in 800-715-9871 (conference ID 6529381). A live audio webcast and replay are available at the company investor website.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
COO is up about 2% while peers show mixed moves: BAX +5.68%, RMD +4.66%, WST +1.76%, SOLV +0.86%, and HOLX -0.11%, indicating stock-specific factors rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 29 | Conference presentation | Neutral | +0.3% | J.P. Morgan Healthcare Conference presentation and webcast availability details. |
| Dec 23 | Board/activist agreement | Neutral | -1.1% | New independent director and cooperation agreement with Browning West. |
| Dec 04 | Strategic review launch | Positive | +1.7% | New Board Chair and formal strategic review with focus on buybacks. |
| Dec 04 | Earnings and guidance | Positive | +1.7% | Q4 and fiscal 2025 results plus fiscal 2026 revenue, EPS and FCF guidance. |
| Nov 04 | Earnings date notice | Neutral | -0.3% | Scheduled Q4 and full-year 2025 results release and conference call details. |
Recent operational and governance news, plus earnings, have seen largely modest single-day price reactions.
Over the last few months, CooperCompanies has issued a mix of governance, strategic, and earnings updates. On Dec 4, 2025, it reported Q4 and full-year 2025 results with fiscal 2025 revenue of $4,092.4M and outlined fiscal 2026 guidance, which saw a positive same-day move. That same day it announced a new Chair and a formal strategic review with a focus on a $2B repurchase program. Subsequent items included a release-date notice and a J.P. Morgan conference appearance, both with relatively small price reactions, similar in nature to today’s scheduling announcement.
Market Pulse Summary
This announcement sets the timetable for CooperCompanies’ Q1 2026 financial results on March 5, 2026, with a conference call at 5:00 PM ET. It mirrors the prior pattern of providing dial-in and webcast access for investors. The more material recent context includes Q4 2025 earnings and fiscal 2026 guidance, as well as the ongoing strategic review and share repurchase focus. Investors may watch how upcoming results track against those previously stated targets.
AI-generated analysis. Not financial advice.
SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.
The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com